COVID-19: A Catalyst for Change for UK Clinical Oncology

The United Kingdom has been severely affected by the coronavirus disease 2019 (COVID-19) pandemic. As the National Health Service (NHS) has urgently prioritized management of this outbreak, the UK clinical oncology community has had to adapt rapidly to maintain cancer services and training. These unprecedented times have altered countless aspects of cancer care, education, and research, providing a legacy that will extend well beyond the pandemic that catalyzed them. This editorial focuses on 3 key themes that distinguish the United Kingdom from many other countries.

Source: International Journal of Radiation Oncology * Biology * Physics - September 2, 2020 Category: Radiology Authors: Charlotte Elizabeth Coles, Ananya Choudhury, Peter J. Hoskin, Christopher M. Jones, Ben O ’Leary, Tom W. Roques, Hannah Tharmalingam, Frances A.P. Yuille Tags: Education and Training Source Type: research